Skip to content

    Organogenesis Holdings (ORGO) stock price & financials

    View ORGO earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance64.0% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $115.18M
    $126.66M
    $86.69M
    $101.00M
    $150.86M
    +31.0%
    $225.61M
    +78.1%
    $37.23M
    -57.1%
    $43.76M
    -56.7%
    Weakening
    Operating Profit
    $6.24M
    $10.22M
    -$26.75M
    -$12.58M
    $20.73M
    +232.1%
    $63.29M
    +519.3%
    -$68.89M
    -157.6%
    -$50.99M
    -305.5%
    Strengthening
    Net Profit
    $12.33M
    $7.67M
    -$18.84M
    -$9.39M
    $21.57M
    +74.9%
    $43.70M
    +469.5%
    -$53.16M
    -182.1%
    -$96.27M
    -925.0%
    Weakening
    EPS
    $0.09
    $-0.17
    $-0.10
    $0.11
    +22.2%
    $-0.44
    -158.8%
    $-0.77
    -670.0%
    Weakening
    Other Income
    -$419.0K
    $34.0K
    $963.0K
    $742.0K
    $433.0K
    $138.0K
    +305.9%
    $418.0K
    -56.6%
    $112.0K
    -84.9%
    Strengthening
    Interest
    $471.0K
    -$61.0K
    -$961.0K
    -$669.0K
    -$415.0K
    -188.1%
    -$236.0K
    -286.9%
    -$380.0K
    +60.5%
    -$138.0K
    +79.4%
    Weakening
    Depreciation
    Profit before Tax
    $5.82M
    $10.25M
    -$25.78M
    -$11.83M
    $21.16M
    +263.4%
    $63.43M
    +518.6%
    -$68.47M
    -165.6%
    -$50.88M
    -329.9%
    Strengthening
    MarginsOPM
    5.4%
    8.1%
    -30.9%
    -12.4%
    13.7%
    +153.5%
    28.1%
    +247.6%
    -185.1%
    -499.8%
    -116.5%
    -836.1%
    Weakening
    Tax
    -111.8%
    25.2%
    26.9%
    20.6%
    -1.9%
    +98.3%
    31.1%
    +23.6%
    22.4%
    -16.9%
    -89.2%
    -532.2%
    Weakening
    ReturnsROIC
    -8.1%
    -5.0%
    12.4%
    6.2%
    -14.1%
    -74.9%
    -28.7%
    -469.5%
    34.9%
    +182.1%
    63.1%
    +925.0%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$21.29M$60.17M$84.39M$113.93M$102.48M$103.84M$135.57M$93.68M$46.10M
    Short-Term Investments
    Total Current Assets$71.13M$125.60M$174.34M$226.98M$222.61M$225.04M$285.94M$362.19M$200.30M
    Net PP&E$39.62M$47.18M$55.79M$128.30M$145.66M$156.35M$126.24M$159.46M$151.44M
    Goodwill$25.54M$25.54M$28.77M$28.77M$28.77M$28.77M$28.77M$28.77M$28.77M
    Intangibles$26.09M$20.80M$30.62M$25.67M$20.79M$15.87M$12.47M$9.14M$3.00M
    Total Assets$163.68M$220.69M$290.22M$443.26M$449.36M$460.02M$497.89M$598.73M$406.45M
    LiabilitiesTotal Current Liabilities$56.10M$59.89M$68.22M$82.70M$75.02M$80.51M$77.48M$100.12M$56.96M
    Short-Term Debt
    Long-Term Debt$49.63M$70.00M$74.06M$71.25M$66.56M
    Long-Term Leases$0$46.89M$20.95M$25.05M$25.20M$22.47M$21.08M
    Total Liabilities$116.64M$165.10M$148.41M$201.92M$183.69M$181.36M$112.57M$164.81M$118.31M
    EquityCommon Stock & APIC$9.0K$10.0K$13.0K$13.0K$13.0K$13.0K$13.0K$13.0K$13.0K
    Retained Earnings-$130.24M-$171.01M-$155.03M-$60.83M-$45.30M-$40.97M-$40.11M-$3.08M-$152.50M
    Total Equity$39.94M$52.02M$141.81M$241.34M$265.67M$278.66M$262.90M$300.13M$148.27M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$60.63M-$33.53M$5.47M$61.98M$24.86M$30.92M$14.21M-$10.31M$31.97M
    Cash from Investing-$1.86M-$6.23M-$23.50M-$31.22M-$33.90M-$24.36M-$10.03M-$14.15M-$11.13M
    Cash from Financing$81.54M$78.73M$42.47M-$1.04M-$2.20M-$5.50M$27.64M-$17.36M-$47.73M
    SummaryCapital Expenditure-$1.86M-$5.98M-$17.68M-$31.22M-$33.90M-$24.36M-$10.03M-$14.15M-$11.13M
    Free Cash Flow-$62.49M-$39.51M-$12.21M$30.76M-$9.04M$6.55M$4.18M-$24.46M$20.84M
    FCF Margin-32.3%-15.1%-3.6%6.6%-2.0%1.5%0.9%-4.3%4.6%

    Ratios